The Role of PPARgamma in Th2 cells and Obesity-Associated Asthma.
PPARgamma 在 Th2 细胞和肥胖相关哮喘中的作用。
基本信息
- 批准号:10058176
- 负责人:
- 金额:$ 11.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdipocytesAdipose tissueAdrenal Cortex HormonesAdvisory CommitteesAffectAgonistAsthmaAtopic DermatitisAwardBiologyBiometryBlood CellsBronchoalveolar Lavage FluidCaliforniaCardiovascular DiseasesCellular biologyChronicClinicalClinical ResearchDataData ScienceData SetDevelopmentDevelopment PlansDisease ManagementDoctor of MedicineDoctor of PhilosophyEffector CellElementsEnvironmentFDA approvedFoundationsFunctional disorderGene ExpressionGene TargetingGenesGenomic approachGoalsHealthHelper-Inducer T-LymphocyteHigh Fat DietHospitalizationHumanImmune responseImmunityImmunologyImmunosuppressive AgentsIn VitroInsulin ResistanceIntentionInterleukin-4InvestigationKidney DiseasesLipidsLiverLiver diseasesLungMapsMeasuresMentorshipMetabolicMolecularMusMuscleNon obeseNon-Insulin-Dependent Diabetes MellitusNuclear Hormone ReceptorsObese MiceObesityPPAR gammaPathogenesisPathologistPatientsPharmaceutical PreparationsPhysiciansPhysiologicalPublic HealthPyroglyphidaeQuality of lifeRefractoryResearchResearch EthicsRisk FactorsRoleSan FranciscoScientistSeveritiesSeverity of illnessSkinSourceT-Cell DevelopmentT-LymphocyteTestingTh2 CellsThiazolidinedionesThinnessTrainingTranscriptional RegulationUnited StatesUniversitiesWorkasthma modelasthmatic patientbasecancer typecareer developmentclinically relevantcomorbiditycostcytokineepidemiology studyfunctional genomicsgene functionin vivolipid biosynthesisloss of functionmembermultidisciplinarynovel therapeutic interventionobesity developmentpre-clinicalprogramsresponserestraintsensortranscriptome sequencing
项目摘要
PROJECT SUMMARY/ABSTRACT
Obesity is a major public health challenge in the United States and worldwide. The chronic complications
and comorbidities from obesity represent one of the greatest challenges to human health. Recent clinical and
epidemiological studies have demonstrated the development of asthma to be strongly associated with obesity.
In fact, obese asthma patients tend to have increased severity of disease and respond poorly to conventional
asthma medications, including corticosteroids. Altogether these observations suggest that obesity-associated
asthma may have a distinct molecular pathophysiology compared to other forms of asthma.
As such, my long-term research goal is to elucidate the molecular, cellular, and physiological
mechanisms that potentiate obesity-associated asthma in order to identify novel therapeutic approaches for the
management of this disease. The objective of this proposal is to determine the role of the nuclear hormone
receptor PPARg (peroxisome proliferator activated receptor gamma) in TH2 cell effector function and obesity-
associated asthma. In previous work, I have discovered that PPARg functions as a brake on TH2 effector function
and that the restraint is abolished in the obese state. My central hypothesis is that obesity dysregulates PPARg in
TH2 cells to potentiate TH2 cell-driven asthma. I will test this hypothesis using two specific aims. In Aim 1, I will
map the PPARg cistrome in TH2 cells isolated directly from the lungs of lean and obese mice being challenged
with experimental asthma to determine if and how the direct and indirect gene targets of PPARg change with
changes in metabolic state. I will also map the PPARg cistrome in in vitro differentiated human TH2 cells. In Aim
2, using lean and obese mice whose T cells are sufficient or deficient in PPARg, I will determine the role of T
cell-specific PPARg in the development of obesity-associated asthma.
I am an M.D., Ph.D.-trained clinical pathologist working as a UCSF StARR Scholar at the University of
California, San Francisco. I am applying for the K38 Award to support my goal of becoming an independent
physician scientist. UCSF's exceptional training environment, especially in the fields of immunology, obesity, and
asthma, will support my efforts in this regard. Critical elements of my career development plan include mentorship
by Dr. Alexander Marson, an expert in utilizing functional genomics approaches to investigate T cell biology in
mouse and human; co-mentorship by Dr. Richard Locksley, an expert in Type 2 immunity, helper T cell
development, and in vivo immunology; co-mentorship by Dr. John Fahy, an expert in translational asthma
research with expertise in obesity-associated asthma; guidance by a multidisciplinary advisory committee which
include senior physician-scientists; coursework in data science (R programing), biostatistics, and research
ethics; and professional development activities. Taken together, this career development plan will establish a
strong foundation on which to build my growing expertise on how obesity alters immune responses.
项目摘要/摘要
肥胖是美国和世界范围内的一项重大公共卫生挑战。慢性并发症
肥胖带来的并存是人类健康面临的最大挑战之一。最近的临床和
流行病学研究表明,哮喘的发展与肥胖密切相关。
事实上,肥胖的哮喘患者往往疾病严重程度增加,对常规治疗的反应较差。
哮喘药物,包括皮质类固醇。总之,这些观察表明,与肥胖相关的
与其他形式的哮喘相比,哮喘可能具有独特的分子病理生理学。
因此,我的长期研究目标是阐明分子、细胞和生理上的
强化肥胖相关哮喘的机制,以确定治疗肥胖相关哮喘的新方法
这种疾病的管理。这项建议的目的是确定核激素的作用
PPARg受体在TH2细胞效应器功能和肥胖中的作用
相关性哮喘。在以前的工作中,我发现PPARg在TH2效应器功能上起到刹车的作用
而在肥胖状态下,这种限制被取消了。我的中心假设是肥胖使PPARg在
Th2细胞增强TH2细胞驱动的哮喘。我将用两个具体目标来检验这一假设。在《目标1》中,我将
直接从瘦肥胖小鼠肺部分离的TH2细胞中PPARg序列的图谱
用实验性哮喘来确定PPARg的直接和间接基因靶点是否以及如何随着
代谢状态的变化。我还将在体外分化的人类TH2细胞中定位PPARg序列。在AIM
2,使用T细胞PPARg充足或不足的瘦小鼠和肥胖小鼠,我将确定T细胞的作用
细胞特异性PPARg在肥胖相关哮喘发生中的作用
我是一名医学博士和博士学位的临床病理学家,在加州大学旧金山分校担任斯塔尔学者。
加利福尼亚州,旧金山。我正在申请K38奖,以支持我成为一名独立人士的目标
内科科学家。加州大学旧金山分校卓越的培训环境,特别是在免疫学、肥胖症和
哮喘,将支持我在这方面的努力。我职业发展计划的关键要素包括指导
亚历山大·马森博士是一位利用功能基因组学方法研究T细胞生物学的专家
小鼠和人类;由2型免疫专家理查德·洛克斯利博士共同指导,辅助T细胞
发育和体内免疫学;转化性哮喘专家约翰·法希博士的共同指导
在与肥胖相关的哮喘方面具有专业知识的研究;由多学科咨询委员会指导,该委员会
包括资深内科科学家;数据科学(R编程)、生物统计学和研究课程
道德操守;以及职业发展活动。综上所述,这项职业发展计划将建立
在此基础上,我在肥胖如何改变免疫反应方面积累了越来越多的专业知识。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sagar Pradeep Bapat其他文献
Sagar Pradeep Bapat的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sagar Pradeep Bapat', 18)}}的其他基金
The Role of PPARgamma in Th2 cells and Obesity-Associated Asthma.
PPARgamma 在 Th2 细胞和肥胖相关哮喘中的作用。
- 批准号:
10242921 - 财政年份:2020
- 资助金额:
$ 11.35万 - 项目类别:
The Role of PPAR Gamma in Fat-Resident Regulatory T Cells and Glucose Homeostasis
PPAR Gamma 在脂肪驻留调节性 T 细胞和血糖稳态中的作用
- 批准号:
8719990 - 财政年份:2012
- 资助金额:
$ 11.35万 - 项目类别:
The Role of PPAR Gamma in Fat-Resident Regulatory T Cells and Glucose Homeostasis
PPAR Gamma 在脂肪驻留调节性 T 细胞和血糖稳态中的作用
- 批准号:
8457922 - 财政年份:2012
- 资助金额:
$ 11.35万 - 项目类别:
The Role of PPAR Gamma in Fat-Resident Regulatory T Cells and Glucose Homeostasis
PPAR Gamma 在脂肪驻留调节性 T 细胞和血糖稳态中的作用
- 批准号:
8569956 - 财政年份:2012
- 资助金额:
$ 11.35万 - 项目类别:
相似海外基金
Deciphering the role of adipose tissue in common metabolic disease via adipose tissue proteomics
通过脂肪组织蛋白质组学解读脂肪组织在常见代谢疾病中的作用
- 批准号:
MR/Y013891/1 - 财政年份:2024
- 资助金额:
$ 11.35万 - 项目类别:
Research Grant
ESTABLISHING THE ROLE OF ADIPOSE TISSUE INFLAMMATION IN THE REGULATION OF MUSCLE MASS IN OLDER PEOPLE
确定脂肪组织炎症在老年人肌肉质量调节中的作用
- 批准号:
BB/Y006542/1 - 财政年份:2024
- 资助金额:
$ 11.35万 - 项目类别:
Research Grant
Canadian Alliance of Healthy Hearts and Minds: Dissecting the Pathways Linking Ectopic Adipose Tissue to Cognitive Dysfunction
加拿大健康心灵联盟:剖析异位脂肪组织与认知功能障碍之间的联系途径
- 批准号:
479570 - 财政年份:2023
- 资助金额:
$ 11.35万 - 项目类别:
Operating Grants
Determinants of Longitudinal Progression of Adipose Tissue Inflammation in Individuals at High-Risk for Type 2 Diabetes: Novel Insights from Metabolomic Profiling
2 型糖尿病高危个体脂肪组织炎症纵向进展的决定因素:代谢组学分析的新见解
- 批准号:
488898 - 财政年份:2023
- 资助金额:
$ 11.35万 - 项目类别:
Operating Grants
Activation of human brown adipose tissue using food ingredients that enhance the bioavailability of nitric oxide
使用增强一氧化氮生物利用度的食品成分激活人体棕色脂肪组织
- 批准号:
23H03323 - 财政年份:2023
- 资助金额:
$ 11.35万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of new lung regeneration therapies by elucidating the lung regeneration mechanism of adipose tissue-derived stem cells
通过阐明脂肪组织干细胞的肺再生机制开发新的肺再生疗法
- 批准号:
23K08293 - 财政年份:2023
- 资助金额:
$ 11.35万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A study on the role of brown adipose tissue in the development and maintenance of skeletal muscles
棕色脂肪组织在骨骼肌发育和维持中作用的研究
- 批准号:
23K19922 - 财政年份:2023
- 资助金额:
$ 11.35万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Adipose Tissue T Cell Polarization and Metabolic Health in Persons Living with HIV
HIV 感染者的脂肪组织 T 细胞极化和代谢健康
- 批准号:
10619176 - 财政年份:2023
- 资助金额:
$ 11.35万 - 项目类别:
Estrogen Signaling in the Ventromedial Hypothalamus Modulates Adipose Tissue Metabolic Adaptation
下丘脑腹内侧区的雌激素信号调节脂肪组织代谢适应
- 批准号:
10604611 - 财政年份:2023
- 资助金额:
$ 11.35万 - 项目类别:
Obesity and Childhood Asthma: The Role of Adipose Tissue
肥胖和儿童哮喘:脂肪组织的作用
- 批准号:
10813753 - 财政年份:2023
- 资助金额:
$ 11.35万 - 项目类别: